Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.4700
-0.0200 (-4.08%)
Mar 31, 2025, 4:00 PM EST - Market closed

Xtant Medical Holdings Stock Forecast

XTNT's stock price has decreased by -59.83% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Xtant Medical Holdings stock has a target of 3.00, which predicts an increase of 538.30% from the current stock price of 0.47.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $3.00 $3.00 $3.00
Change +538.30% +538.30% +538.30% +538.30%
* Price targets were last updated on May 16, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Xtant Medical Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 22221
Buy 00000
Hold 00000
Sell 00000
Strong Sell 00000
Total 22221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Strong Buy
Maintains
$2$3
Strong Buy Maintains $2$3 +538.30% May 16, 2024
BTIG
BTIG
Strong Buy
Initiates
$2
Strong Buy Initiates $2 +325.53% Dec 5, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$1$1.2
Strong Buy Maintains $1$1.2 +155.32% Jul 11, 2023
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$1
Strong Buy Initiates $1 +112.77% Apr 26, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
135.51M
from 117.27M
Increased by 15.56%
Revenue Next Year
165.85M
from 135.51M
Increased by 22.39%
EPS This Year
-0.04
from -0.12
EPS Next Year
-0.01
from -0.04
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
53.34M55.26M57.97M91.30M117.27M135.51M165.85M
Revenue Growth
-17.54%3.61%4.90%57.50%28.44%15.56%22.39%
EPS
-0.25-0.06-0.090.01-0.12-0.04-0.01
EPS Growth
-------
Forward PE
-------
No. Analysts -----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 146.1M 170.7M
Avg 135.5M 165.9M
Low 124.1M 159.4M

Revenue Growth

Revenue Growth 20252026
High
24.6%
26.0%
Avg
15.6%
22.4%
Low
5.8%
17.6%

EPS Forecast

EPS 20252026
High -0.02 -
Avg -0.04 -0.01
Low -0.05 -0.01

EPS Growth

EPS Growth 20252026
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.